vaccine
A scientist’s opinion : Interview with Professor Johan Neyts about COVID-19 vaccines
Johan Neyts is full professor of virology at the University of Leuven, Belgium. He teaches virology at the medical school and at the school of dentistry. His lab is deeply involved in the development of antivirals against SARS-CoV-2. A second focus of the lab is the development of novel vaccine technologies. To that end, the yellow ...
A scientist’s opinion : Interview with Professor Earl Brown about COVID-19 vaccines
Professor Earl Brown is specialized in virology and microbiology. His main activities are on viral genetics and evolution, mainly directed at understanding how viruses cause disease (pathogenesis) or become adapted to new hosts; and the mechanism used by influenza virus to control the antiviral interferon response. He has experience with several viruses, including hepatitis C, ...
Covid-19: different types of vaccines and how they work
A range of Covid-19 vaccines are being developed worldwide and the differences between them can be confusing. How do the new mRNA vaccines work? What about vector vaccines? We asked scientists to give us an insight into the different types of Covid-19 vaccines.
European responses to the corona crisis – Part 13
During the Coronavirus crises, the European Science-Media Hub is collecting and publishing a regular update of the most relevant releases provided by EU institutions and other European and global actors. 🆕 Last Update : 25 Feb 2021
A scientist’s opinion : Interview with Samuel Scarpino about clusters & superspreading
Interview with Samuel Scarpino, assistant professor in the Network Science Institute at Northeastern University in Boston, Massachusetts. What impact does the news about fresh vaccines for COVID-19 have on the importance of backward tracing? With the new vaccines, I think certainly the early signs are a lot more optimistic than most of us were planning ...
A scientist’s opinion : Interview with Dr Akira Endo about clusters & superspreading
Interview with Dr Akira Endo in the Department of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine. Is it still beneficial to look into combining backward with forward contact tracing, as you describe in your recent paper, following the recent developments with COVID vaccines? It’s very good news about the vaccines, ...
Mix of COVID-19 cluster-busting with vaccine push may bring a new normal faster
Combining so-called “backward tracing” with traditional forward tracing to help identify source events of COVID-19 outbreaks has been cited as a potential way of better tracking the disease, as seen in some Asian countries. Now that vaccines are emerging on the scene, how can this concept be used for more effective cluster-busting?
An expert’s opinion: An interview with Ayman El-Mohandes on COVID-19 vaccine acceptance and public health messaging
Ayman El-Mohandes, Dean of City University of New York Graduate School of Public Health and Health Policy (CUNY SPH) and co-coordinator of a global survey on potential hesitancy to accept a proven, safe and effective COVID-19 vaccine, speaks to us about the findings and their implications for halting the spread of the virus. What does ...
An expert’s opinion: An interview with Melinda Mills on the behavioural factors underlying COVID-19 vaccine uptake
We speak with Melinda Mills, Director of the Leverhulme Centre for Demographic Science at the University of Oxford and lead author of the British Academy and Royal Society report on Vaccine Deployment. She calls for open dialogue about vaccine concerns and the need to help people spot misinformation. How did the Vaccine Deployment report come ...
Vaccination policy in times of Covid-19
As multiple COVID-19 vaccines are emerging, what can be done to tackle vaccination hesitancy and ensure rapid and equitable deployment?